PCD logo

Geographic and Sociodemographic Patterns in Prevalence of Diagnosed Diabetes, US, 2021–2024

Nicholas Yell, PhD1; Michelle Asiedu-Danso, MPH2; Cassie L. Odahowski, PhD3; Elizabeth Crouch, PhD1; Gabriel A. Benavidez, PhD2 (View author affiliations)

PEER REVIEWED

Summary

What is already known on this topic?

Diabetes prevalence is higher among population groups who consistently experience social and economic challenges.

What is added by this report?

This study provides an updated national analysis of diabetes prevalence, highlighting how rurality interacts with socioeconomic and demographic characteristics in contributing to the burden of diabetes.

What are the implications for public health practice?

Tailored prevention and management strategies are needed to address the disproportionate diabetes prevalence in rural communities, particularly among young adults and racial and socioeconomic groups with less access to health care services.

Abstract

Using pooled data from the 2021–2024 National Health Interview Survey, we compared the prevalence of diagnosed diabetes among rural and urban adults (≥18 y) across multiple sociodemographic factors by using survey-weighted descriptive statistics and t tests. Overall prevalence was 9.8%, with higher rates among rural residents (12.3%) than urban residents (9.3%) (P < .001); differences persisted across most sociodemographic groups, including by income, education, and race and ethnicity, but were absent among adults aged 65 years or older. The higher prevalence among rural residents compounds existing socioeconomic and racial and ethnic inequities, highlighting the need to monitor both rural–urban and within-rural differences and to prioritize tailored prevention and management strategies.

Top

Objective

As of 2023, 11.3% of the US population had been diagnosed with diabetes (1). Projections suggest that one-third of the US population may be diagnosed with diabetes by 2050 (2). While diabetes is the 7th leading underlying cause of death in the US (3), its true impact on mortality rates is likely undercounted. It contributes significantly to other leading causes of death, such as heart disease, stroke, and kidney disease, making it a major driver of premature death and reduced life expectancy (4).

The prevalence of diabetes is not evenly distributed. Racial and ethnic minority groups, people with low income or educational attainment, and those living in rural areas experience disproportionately higher rates of diabetes and its complications (5,6). These differences reflect broader intersecting structural and geographic patterns in health risk and access to care. However, less is known about the dual effects of rurality and other sociodemographic and economic characteristics and the burden of diabetes throughout the population.

National estimates often mask variation in rural areas, where populations are not homogenous. Single-year survey prevalence estimates often lack sufficient sample sizes to support meaningful rural–urban comparisons, particularly when further stratifying by sociodemographic characteristics. As a result, within-rural differences may be obscured, limiting the ability to tailor rural-specific interventions.

We analyzed national data by rurality status to provide the most current estimates of diabetes prevalence across the US population. These findings can support more precise public health strategies and inform resource allocation efforts that reflect the needs unique to rural and urban populations.

Top

Methods

This cross-sectional study pooled data from the 2021–2024 National Health Interview Survey (NHIS), a nationally representative, annual household survey conducted by the National Center for Health Statistics (NCHS) to assess the health of noninstitutionalized US residents. The analytic sample comprised adults aged 18 or older who responded to the survey question asking whether a health professional had ever told them that they had diabetes.

The primary outcome was the prevalence of diagnosed diabetes, calculated as the proportion of respondents who reported that a health professional had ever told them that they had diabetes. The main independent variable was rurality, classified according to the NCHS Urban–Rural Classification Scheme for Counties and defined as rural if the respondent lived in a nonmetropolitan area and urban if otherwise (7). Additional covariates were survey year, sex, age group, body mass index (BMI), education level, race and ethnicity, primary insurance type, income-to-poverty ratio, food security status, and self-rated general health.

All analyses incorporated NHIS’s raking-derived weights and accounted for the survey’s complex design. The survey weights were adjusted proportionally to account for the pooled multiyear sample. Data management and analyses were conducted in SAS 9.4 (SAS Institute Inc). Descriptive statistics were used to examine the weighted diagnosed diabetes prevalence across rurality and sociodemographic factors. We used Rao–Scott c2 tests to assess whether rural and urban prevalence rates differed significantly within each subgroup. The degrees of freedom were 1 and the tests were 1-tailed. This study was exempt from institutional review board review because it used only publicly available, de-identified data.

Top

Results

The overall weighted adult diabetes prevalence was 9.8%, with a higher prevalence among rural residents (12.3%) compared with urban residents (9.3%) (P < .001) (Table). This rural–urban difference persisted across most subgroups. Diabetes was more common among men than women in both settings, but the prevalence was higher among rural men (12.7%) and women (12.0%) than it was among their urban counterparts.

Prevalence increased with age, but rural residents consistently had higher prevalence except among those aged 65 years or older where no rural–urban difference was observed. Diabetes prevalence rose with increasing BMI, and rural residents had higher rates across most BMI categories, except for those who were underweight. Diabetes decreased with higher educational attainment, and rural–urban differences were observed at the high school graduate level and above with rural residents consistently showing higher prevalence. Diabetes was more common among people with low income. Among those with income below the federal poverty level (FPL), rural residents had a higher prevalence (16.1%) than urban residents (13.4%; P = .004). This gap persisted among residents at or above the FPL (11.7% rural vs 8.9% urban; P < .001). The only insurance category without a rural–urban difference was the uninsured.

Rural–urban differences were observed among non-Hispanic White, Black, and non-Hispanic other populations that included non-Hispanic Asian and American Indian populations with rural residents having a higher prevalence. Differences among Hispanic people were not observed. Diabetes prevalence was higher among those with marginal or lower versus high food security (13.9% vs 9.1%, respectively, overall); within both food-security strata, rural residents had higher prevalences of diabetes than did urban residents: high food security, 11.4% versus 8.7% (P < .001); marginal or lower, 17.1% versus 13.3% (P < .001).

Top

Discussion

Using pooled data from 4 years of NHIS, we observed consistently higher diabetes prevalence among rural residents compared with urban residents, a finding that aligns with prior research (8,9). Across both rural and urban populations, diabetes prevalence increased with age. Significant rural–urban differences were observed only for adults aged less than 65 years. Among adults aged 65 or older, prevalence was similar across both groups. Concentration of high diabetes prevalence in working-age adults in rural areas signals future demand for diabetes care as these cohorts age with implications for complications, mortality rates, costs, and strain on rural health systems (10). Tailored prevention efforts and risk-factor control earlier in adulthood, plus stronger rural primary care and care management, are warranted because services, such as diabetes education, are already limited (11).

Diabetes prevalence declined as level of education and income increased. However, rural residents had significantly higher prevalence at nearly every level of education and income, suggesting that rurality amplifies the impact of socioeconomic status, even among those with more resources. Across racial and ethnic groups, rural residents consistently experienced a higher prevalence of diabetes, particularly among non-Hispanic people. Previous research has documented that rural residence can negatively compound the effects of race and socioeconomic status on health outcomes (12).

Although diabetes was more common overall among respondents with marginal or lower food security than those with high food security, the rural–urban gap persisted across both levels with the largest absolute difference observed in the marginal or lower food security group. These findings highlight the potential dual role of food insecurity and rural residence consistent with prior work linking limited food access, care shortages, and structural barriers in rural settings to higher diabetes burden.

This study has limitations, notably the reliance on self-reported data and potential underreporting of diabetes diagnoses. Additionally, our estimates are crude and not age-adjusted, so rural–urban differences may partly reflect underlying age composition. We prioritized crude prevalence as a measure to quantify population burden and avoid instability in small rural subgroups; findings are descriptive and should not be interpreted as age-independent contrasts. Nonetheless, this analysis confirms that rural residents continue to face a disproportionate diabetes burden across most demographic and socioeconomic strata. These findings underscore the need for geographically tailored public health strategies and the importance of tracking not only rural–urban differences but also within-rural variation across sociodemographic groups. This tracking will be increasingly critical as new pharmaceutical interventions, such as glucagon-like peptide-1 (GLP-1) receptor agonists, offer promising opportunities to reduce diabetes incidence. Identifying which populations are being left behind will be essential to ensuring tailored prevention strategies and uniform access to emerging treatments.

Top

Acknowledgments

This project was supported by the Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number #U1C45498, Rural Health Research Grant Program Cooperative Agreement. This information, content, and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the US Government.

The authors have no relevant financial or nonfinancial conflicts of interest to disclose.

The conceptualization and methodology were done by Nicholas Yell, Michelle Asiedu-Danso, Gabriel A. Benavidez, and Elizabeth Crouch. All authors contributed to the interpretation of data. The acquisition of data was done by Michelle Asiedu-Danso. The analysis was done by Nicholas Yell. Data curation was done by Nicholas Yell and Michelle Asiedu-Danso. The first draft of the manuscript was written by Nicholas Yell and Michelle Asiedu-Danso, and all authors reviewed and edited preceding versions. The first draft of the visualization was created by Nicholas Yell, and Nicholas Yell, Michelle Asiedu-Danso, Gabriel A. Benavidez, and Elizabeth Crouch reviewed and edited preceding versions. Supervision and project administration were done by Elizabeth Crouch. The guarantor of this work is Nicholas Yell.

All datasets used for analysis are available via the NHIS website, https://www.cdc.gov/nchs/nhis/index.html.

Top

Author Information

Corresponding Author: Gabriel A. Benavidez, PhD, Assistant Professor, Department of Public Health, Robbins College of Health and Human Sciences, Baylor University, Waco, TX 76798-7151 (Gabriel_benavidez@baylor.edu).

Author Affiliations: 1Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina. 2Department of Public Health, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas. 3Arnold School of Public Health, University of South Carolina, Columbia, South Carolina.

Top

References

  1. Gwira JA, Fryar CD, Gu Q. Prevalence of total, diagnosed, and undiagnosed diabetes in adults: United States, August 2021–August 2023. Centers for Disease Control and Prevention. Accessed July 22, 2025. https://www.cdc.gov/nchs/products/databriefs/db516.htm
  2. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8(1):29. PubMed https://doi.org/10.1186/1478-7954-8-29
  3. Murphy SL, Kochanek KD, Xu J, Arias E. Mortality in the United States, 2023. Centers for Disease Control and Prevention. 2024. Accessed August 27, 2025. https://www.cdc.gov/nchs/data/databriefs/db521.pdf
  4. Ahmed M, Zulfiqar E, Shafiq A, Shahzad M, Hashmi TM, Ahmed R, et al. Type 2 diabetes mellitus-related mortality in the United States, 1999 to 2023. JACC Adv. 2025;4(7):101882. PubMed https://doi.org/10.1016/j.jacadv.2025.101882
  5. Tatulashvili S, Fagherazzi G, Dow C, Cohen R, Fosse S, Bihan H. Socioeconomic inequalities and type 2 diabetes complications: a systematic review. Diabetes Metab. 2020;46(2):89–99. PubMed https://doi.org/10.1016/j.diabet.2019.11.001
  6. Dugani SB, Lahr BD, Xie H, Mielke MM, Bailey KR, Vella A. County rurality and incidence and prevalence of diagnosed diabetes in the United States. Mayo Clin Proc. 2024;99(7):1078–1090. PubMed https://doi.org/10.1016/j.mayocp.2023.11.022
  7. Centers for Disease Control and Prevention. NCHS urban–rural classification scheme for counties. September 17, 2024. Accessed August 26, 2025. https://www.cdc.gov/nchs/data-analysis-tools/urban-rural.html
  8. Khavjou O, Tayebali Z, Cho P, Myers K, Zhang P. Rural–urban disparities in state-level diabetes prevalence among US adults, 2021. Prev Chronic Dis. 2025;22:E05. PubMed https://doi.org/10.5888/pcd22.240199
  9. McAlexander TP, Malla G, Uddin J, Lee DC, Schwartz BS, Rolka DB, et al. Urban and rural differences in new onset type 2 diabetes: comparisons across national and regional samples in the diabetes LEAD network. SSM Popul Health. 2022;19:101161. PubMed https://doi.org/10.1016/j.ssmph.2022.101161
  10. Nielsen M, D’Agostino D, Gregory P. Addressing rural health challenges head on. Mo Med. 2017;114(5):363–366. PubMed
  11. Probst JC, Yell N, Benavidez GA, McNatt MK, Browne T, Herbert L, et al. Dialysis more available than patient education in counties with high diabetes prevalence. Prev Chronic Dis. 2024;21:E60. PubMed https://doi.org/10.5888/pcd21.240052
  12. Probst JC, Moore CG, Glover SH, Samuels ME. Person and place: the compounding effects of race/ethnicity and rurality on health. Am J Public Health. 2004;94(10):1695–1703. PubMed https://doi.org/10.2105/AJPH.94.10.1695

Top

Tables

Return to your place in the text

Table. Diabetes Prevalence, by Rurality and Sociodemographic Characteristics, National Health Interview Survey, 2021–2024
Demographic characteristic Overall Na Overall diabetes prevalence (95% CI) Rural Na Rural diabetes prevalence (95% CI) Urban Na Urban diabetes prevalence (95% CI) P value
Overall 119,160 9.8 (9.5–10.0) 20,393 12.3 (11.6–13.0) 98,767 9.3 (9.1–9.6) <.001
Sex
Men 54,346 10.2 (9.9–10.5) 9,284 12.7 (11.8–13.6) 45,062 9.8 (9.5–10.1) <.001
Women 64,798 9.3 (9.0–9.6) 11,109 12.0 (11.1–12.9) 53,689 8.9 (8.6–9.2) <.001
Age, y
18–24 7,423 1.0 (0.7–1.2) 1,100 1.6 (0.8–2.5) 6,323 0.9 (0.6–1.1) .03
25–34 17,298 1.7 (1.5–2.0) 2,324 2.5 (1.6–3.5) 14,974 1.6 (1.3–1.9) .02
35–44 18,609 4.5 (4.1–4.9) 2,523 6.7 (5.4–8.0) 16,086 4.2 (3.8–4.6) <.001
45–54 16,655 10.0 (9.4–10.6) 2,700 12.6 (10.8–14.3) 13,955 9.6 (9.0–10.2) <.001
55–64 20,719 15.4 (14.8–16.0) 3,898 17.8 (16.2–19.4) 16,821 15.0 (14.3–15.6) <.001
≥65 38,198 20.2 (19.6–20.7) 7,823 20.8 (19.7–22.0) 30,375 20.0 (19.4–20.7) .24
Body mass index
Underweight 1,907 3.2 (2.2–4.2) 314 4.3 (1.6–6.9) 1,593 3.0 (2.0–4.1) .35
Healthy weight 36,474 4.8 (4.5–5.1) 5,191 5.8 (5.0–6.5) 31,283 4.7 (4.4–4.9) .003
Overweight 39,904 9.0 (8.7–9.4) 6,552 11.0 (9.9–12.0) 33,352 8.7 (8.4–9.1) <.001
Obese 38,318 15.5 (15.0–15.9) 7,918 17.7 (16.6–18.8) 30,400 15.0 (14.5–15.5) <.001
Education level
Less than high school diploma 10,075 16.9 (16.0–17.8) 2,304 17.9 (15.9–20.0) 7,771 16.7 (15.7–17.7) .28
High school diploma or GED only 30,135 11.3 (10.9–11.7) 7,164 12.9 (12.0–13.9) 22,971 10.9 (10.4–11.4) <.001
Some college or associate’s degree 33,049 9.8 (9.4–10.1) 6,206 12.0 (11.0–12.9) 26,843 9.4 (9.0–9.8) <.001
Bachelor’s degree or higher 45,315 6.2 (6.0–6.5) 4,645 8.0 (7.1–8.9) 40,670 6.1 (5.8–6.3) <.001
Race and ethnicity
Non-Hispanic White 79,080 8.9 (8.6–9.1) 16,764 11.9 (11.2–12.6) 62,316 8.2 (7.9–8.5) <.001
Non-Hispanic Black 12,768 12.7 (12.0–13.4) 1,477 15.9 (13.5–18.2) 11,291 12.4 (11.7–13.1) .002
Hispanic 17,196 10.7 (10.1–11.4) 1,148 12.2 (9.4–15.0) 16,048 10.7 (10.0–11.3) .27
Non-Hispanic otherb 10,116 10.2 (9.4–10.9) 1,004 14.4 (11.8–17.0) 9,112 9.8 (9.1–10.5) <.001
Primary insurance type
Public 32,846 16.2 (15.7–16.7) 6,413 17.3 (16.1–18.5) 26,433 16.0 (15.4–16.5) .048
Private 70,027 7.3 (7.0–7.5) 10,879 9.9 (9.1–10.6) 59,148 6.9 (6.6–7.1) <.001
Other 7,127 18.1 (17.0–19.2) 1,449 21.7 (19.3–24.1) 5,678 17.4 (16.2–18.6) .001
Uninsured 8,741 4.9 (4.4–5.4) 1,578 5.4 (4.1–6.8) 7,163 4.8 (4.2–5.3) .36
Ratio of family income to FPL
<100% of FPL 12,197 13.9 (13.2–14.7) 2,980 16.1 (14.4–17.8) 9,217 13.4 (12.6–14.3) .004
≥100% of FPL 106,963 9.3 (9.1–9.5) 17,413 11.7 (11.0–12.4) 89,550 8.9 (8.7–9.2) <.001
Food security
High 98,630 9.1 (8.8–9.3) 16,678 11.4 (10.7–12.1) 81,952 8.7 (8.5–9.0) <.001
Marginal or less 15,406 13.9 (13.2–14.5) 3,045 17.1 (15.4–18.8) 12,361 13.3 (12.5–14.0) <.001
General health status
Excellent 24,653 1.4 (1.2–1.5) 3,131 1.8 (1.4–2.3) 21,522 1.3 (1.2–1.5) .03
Very good 40,347 4.6 (4.4–4.8) 6,285 5.3 (4.8–5.9) 34,062 4.5 (4.2–4.7) .006
Good 35,344 13.3 (12.9–13.7) 6,610 14.7 (13.6–15.9) 28,734 13.1 (12.6–13.5) .006
Fair or poor 18,766 27.4 (26.6–28.2) 4,359 28.6 (26.7–30.5) 14,407 27.2 (26.3–28.0) .17

Abbreviation: FPL, federal poverty level; GED, general equivalency diploma.
a Unweighted frequencies of survey participants in each category.
b Includes non-Hispanic Asian and American Indian populations.

Top


The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.